ReviewFrontiers in microbiology2026
The role of Western diet and gut microbiota in the pathogenesis of cardiovascular diseases.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Diet-Associated Regulation of Cardiac Metabolism: Molecular Determinants and Pathophysiological Consequences.Nutrients · 2026Review
- Psyllium and Glucomannan as Viscous Fiber Modulators of the Gut-Microbiome-Incretin Axis: Molecular Links to Metabolic Inflammation, Barrier Function, and GLP-1 Receptor Agonist Therapy.International journal of molecular sciences · 2026Review
- Gut Microbiome-Hormone Interactions and Precision Fermentation in the Prevention of Early Cardiovascular Risk in Adolescents.International journal of molecular sciences · 2026Review
- Nutritional interventions for late-life depression: evidence, mechanisms, and clinical assessment tools.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Western diet (WD) is characterized by high fat, high sugar, high salt and low fiber. WD can disrupt the homeostasis of the intestinal flora and become an important factor in the occurrence and development of Cardiovascular Diseases (CVD). This review elucidates the core mechanism through which WD-induced intestinal flora dysbiosis contributes to the development of CVD. Specifically, the disruption of intestinal barrier function promotes the generation of pathogenic metabolites, such as trimethylamine-N-oxide (TMAO), while simultaneously suppressing the production of beneficial metabolites, including short-chain fatty acids (SCFAs). This metabolic shift subsequently triggers systemic inflammatory responses, oxidative stress, and metabolic disturbances, thereby accelerating the progression of CVD-related conditions, such as atherosclerosis and hypertension. Meanwhile, this review systematically summarizes key intervention strategies targeting the gut microbiota. Accumulating evidence indicates that interventions such as probiotics, prebiotics, the Mediterranean diet, and fecal microbiota transplantation (FMT) can effectively restore intestinal microbial homeostasis, enhance the production of SCFAs, and mitigate the risk of CVD. Notably, long-term dietary patterns have demonstrated significant efficacy in reshaping the gut ecosystem, underscoring the importance of sustainable lifestyle modifications. Therefore, this study aims to integrate current knowledge regarding the underlying molecular mechanisms and provide a theoretical basis for developing precise interventions to prevent and treat CVD through modulation of the gut microbiota.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.